HEADER TRANSCRIPTION 26-JAN-07 2JNJ TITLE SOLUTION STRUCTURE OF THE P8 TFIIH SUBUNIT COMPND MOL_ID: 1; COMPND 2 MOLECULE: TFIIH BASAL TRANSCRIPTION FACTOR COMPLEX TTD-A SUBUNIT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GENERAL TRANSCRIPTION FACTOR IIH POLYPEPTIDE 5, TFB5 COMPND 5 ORTHOLOG; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GTF2H5, TTDA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PGEX KEYWDS PROTEIN, TRANSCRIPTION, STRUCTURAL GENOMICS, STRUCTURAL PROTEOMICS IN KEYWDS 2 EUROPE 2, SPINE-2 EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.VITORINO,R.A.ATKINSON,D.MORAS,A.POTERSZMAN,B.KIEFFER,STRUCTURAL AUTHOR 2 PROTEOMICS IN EUROPE 2 (SPINE-2) REVDAT 4 20-DEC-23 2JNJ 1 REMARK REVDAT 3 09-MAR-22 2JNJ 1 KEYWDS AUTHOR REMARK SEQADV REVDAT 2 24-FEB-09 2JNJ 1 VERSN REVDAT 1 10-APR-07 2JNJ 0 JRNL AUTH M.VITORINO,F.COIN,O.ZLOBINSKAYA,R.A.ATKINSON,D.MORAS, JRNL AUTH 2 J.M.EGLY,A.POTERSZMAN,B.KIEFFER JRNL TITL SOLUTION STRUCTURE AND SELF-ASSOCIATION PROPERTIES OF THE P8 JRNL TITL 2 TFIIH SUBUNIT RESPONSIBLE FOR TRICHOTHIODYSTROPHY JRNL REF J.MOL.BIOL. V. 368 473 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17350038 JRNL DOI 10.1016/J.JMB.2007.02.020 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH, X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X-PLOR REMARK 3 NIH), SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X- REMARK 3 PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NMR WATERREFINE PROTOCOL REMARK 4 REMARK 4 2JNJ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000100055. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 300 UM [U-99% 13C, U-99% 15N] REMARK 210 PROTEIN, 2.5 MM BETA- REMARK 210 MERCAPTOETHANOL, 50 MM SODIUM REMARK 210 CHLORIDE, 10 MM TRIS, 90% H2O/10% REMARK 210 D2O; 300 UM PROTEIN, 2.5 MM REMARK 210 BETA-MERCAPTOETHANOL, 50 MM REMARK 210 SODIUM CHLORIDE, 10 MM TRIS, 90% REMARK 210 H2O/10% D2O; 300 UM [U-99% 15N] REMARK 210 PROTEIN, 2.5 MM BETA- REMARK 210 MERCAPTOETHANOL, 50 MM SODIUM REMARK 210 CHLORIDE, 10 MM TRIS, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 3D HNCO; 3D HNCA; 3D HNCACB; 3D REMARK 210 HN(CO)CA; 3D HCCH-TOCSY; 3D HCCH- REMARK 210 COSY; 3D 1H-15N NOESY; 3D 1H-15N REMARK 210 TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY, ARIA, TALOS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ1 LYS A 20 OD1 ASP A 40 1.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 17 0.57 -56.28 REMARK 500 1 ASP A 42 100.25 45.65 REMARK 500 1 ASP A 43 -46.23 68.82 REMARK 500 1 GLN A 66 141.83 -171.95 REMARK 500 1 PHE A 69 77.23 -102.25 REMARK 500 1 GLN A 73 -29.33 -176.25 REMARK 500 1 SER B 2 -62.56 -90.26 REMARK 500 1 CYS B 15 -64.16 -150.08 REMARK 500 1 ASP B 42 86.57 -27.93 REMARK 500 1 ASP B 43 -54.37 62.33 REMARK 500 1 GLN B 66 153.31 157.68 REMARK 500 1 GLN B 73 -36.89 -144.12 REMARK 500 2 SER A 2 -56.49 -155.40 REMARK 500 2 VAL A 5 92.66 32.15 REMARK 500 2 ASP A 42 72.20 58.71 REMARK 500 2 ASP A 43 -48.83 69.05 REMARK 500 2 GLN A 66 127.93 157.51 REMARK 500 2 GLN A 73 -19.67 168.85 REMARK 500 2 CYS B 15 -62.91 -158.34 REMARK 500 2 ASP B 16 130.31 -173.12 REMARK 500 2 ASN B 30 71.97 59.09 REMARK 500 2 ASP B 42 87.43 54.02 REMARK 500 2 ASP B 43 -41.42 67.27 REMARK 500 2 GLN B 66 113.54 156.88 REMARK 500 2 LEU B 71 75.08 -153.80 REMARK 500 2 GLN B 73 18.19 -153.34 REMARK 500 3 VAL A 5 102.48 -59.73 REMARK 500 3 CYS A 15 -77.15 -128.28 REMARK 500 3 ASP A 16 125.31 -178.26 REMARK 500 3 ASN A 30 74.68 61.77 REMARK 500 3 ASP A 42 89.45 -32.33 REMARK 500 3 ASP A 43 -23.34 54.98 REMARK 500 3 GLN A 66 120.92 161.58 REMARK 500 3 SER A 70 100.83 -36.03 REMARK 500 3 THR A 72 -47.17 -166.35 REMARK 500 3 SER B 2 -72.96 -98.92 REMARK 500 3 CYS B 15 -165.76 -115.82 REMARK 500 3 ASP B 43 -25.04 62.70 REMARK 500 3 GLN B 66 113.96 165.76 REMARK 500 4 HIS A 3 -35.73 -135.16 REMARK 500 4 MET A 4 -83.57 -116.52 REMARK 500 4 VAL A 5 97.48 29.08 REMARK 500 4 CYS A 15 -164.31 -162.51 REMARK 500 4 PRO A 17 -11.79 -45.80 REMARK 500 4 ASN A 30 83.31 54.59 REMARK 500 4 ASP A 42 92.07 -21.29 REMARK 500 4 ASP A 43 -38.02 66.60 REMARK 500 4 GLN A 66 119.58 152.58 REMARK 500 4 THR A 72 -36.47 -165.53 REMARK 500 4 CYS B 15 -156.91 -165.65 REMARK 500 REMARK 500 THIS ENTRY HAS 123 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2JNJ A 4 74 UNP Q6ZYL4 TF2H5_HUMAN 1 71 DBREF 2JNJ B 4 74 UNP Q6ZYL4 TF2H5_HUMAN 1 71 SEQADV 2JNJ GLY A 1 UNP Q6ZYL4 CLONING ARTIFACT SEQADV 2JNJ SER A 2 UNP Q6ZYL4 CLONING ARTIFACT SEQADV 2JNJ HIS A 3 UNP Q6ZYL4 CLONING ARTIFACT SEQADV 2JNJ GLY B 1 UNP Q6ZYL4 CLONING ARTIFACT SEQADV 2JNJ SER B 2 UNP Q6ZYL4 CLONING ARTIFACT SEQADV 2JNJ HIS B 3 UNP Q6ZYL4 CLONING ARTIFACT SEQRES 1 A 74 GLY SER HIS MET VAL ASN VAL LEU LYS GLY VAL LEU ILE SEQRES 2 A 74 GLU CYS ASP PRO ALA MET LYS GLN PHE LEU LEU TYR LEU SEQRES 3 A 74 ASP GLU SER ASN ALA LEU GLY LYS LYS PHE ILE ILE GLN SEQRES 4 A 74 ASP ILE ASP ASP THR HIS VAL PHE VAL ILE ALA GLU LEU SEQRES 5 A 74 VAL ASN VAL LEU GLN GLU ARG VAL GLY GLU LEU MET ASP SEQRES 6 A 74 GLN ASN ALA PHE SER LEU THR GLN LYS SEQRES 1 B 74 GLY SER HIS MET VAL ASN VAL LEU LYS GLY VAL LEU ILE SEQRES 2 B 74 GLU CYS ASP PRO ALA MET LYS GLN PHE LEU LEU TYR LEU SEQRES 3 B 74 ASP GLU SER ASN ALA LEU GLY LYS LYS PHE ILE ILE GLN SEQRES 4 B 74 ASP ILE ASP ASP THR HIS VAL PHE VAL ILE ALA GLU LEU SEQRES 5 B 74 VAL ASN VAL LEU GLN GLU ARG VAL GLY GLU LEU MET ASP SEQRES 6 B 74 GLN ASN ALA PHE SER LEU THR GLN LYS HELIX 1 1 PRO A 17 ASN A 30 1 14 HELIX 2 2 LEU A 52 LEU A 63 1 12 HELIX 3 3 ASP B 16 ASN B 30 1 15 HELIX 4 4 LEU B 52 LEU B 63 1 12 SHEET 1 A 5 ILE A 37 ILE A 41 0 SHEET 2 A 5 HIS A 45 VAL A 48 -1 O PHE A 47 N ILE A 38 SHEET 3 A 5 ASN A 6 GLU A 14 -1 N ILE A 13 O VAL A 46 SHEET 4 A 5 LEU B 8 GLU B 14 -1 O LEU B 12 N LEU A 8 SHEET 5 A 5 HIS B 45 VAL B 48 -1 O VAL B 48 N VAL B 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1